Delivery Order SPE2DB20D3103-SPE2DB26FL4Z8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lenvima 8 mg daily dose tablets (60-unit supply) on October 27, 2025, with completion targeted for November 18, 2025. This award represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count package) valued at $29,732.85. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count) on June 18, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units. The order is a firm fixed price delivery order with an ultimate completion date of November 18, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lenvima 14 mg daily dose (60-count package), with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count supply) on November 3, 2025, with completion targeted for November 25, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for Lenvima 10 mg daily dose tablets (30-count package) on June 30, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in a 90-day supply. The contract, executed on April 24, 2025, with completion targeted for May 15, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4Z8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts with the DLA and Defense Health Agency, supporting critical medical procurement needs across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 11/4/25 |